Topics:
Pediatric Oncology • Thrombocytopenia • Hematology • Pediatric Hematology • Benign Hematology • ITP
How do you approach an ITP patient who responds very well to steroids but the response is short-lived?
How would you counsel the patient if he/she wants to continue on steroids?
Answer from: at Academic Institution
Rituximab is probably no longer the treatment of choice for ITP secondary therapy for the majority of patients. Although it has a good initial response, the majority of patients relapse in the first 1 to 2 years leaving a choice of retreating and persistent immunosuppression or trying another therap...
Answer from: at Community Practice
All choices may apply, depending on the patient's tolerance and specific health issues.
Agree, rituximab or TPO agonist depending on the s...